Patrice P. Denefle
Geen lopende functies
Profiel
Patrice P.
Denefle worked as the Chief Scientific Officer at Genethon and 4P-Pharma.
He also served as the Chief Scientific Officer at Centogene NV from 2021 to 2023.
Dr. Denefle completed his undergraduate degree at Université De Lille.
Eerdere bekende functies van Patrice P. Denefle
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTOGENE N.V. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 |
| 4P-Pharma | Hoofd Techniek/Wetenschap/O&O | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Patrice P. Denefle
| Université De Lille | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
| 4P-Pharma | Commercial Services |
